Abu Dhabi Opens Pre-Approval Tasting Pathway for Cultivated Meat and Precision-Fermented Foods

Abu Dhabi has introduced a formal framework that allows companies developing cultivated meat, precision-fermented ingredients and other novel foods to run human tasting and sensory evaluation studies before their products receive full UAE market approval, addressing one of the most persistent gaps in alternative protein commercialisation.

The Abu Dhabi Guideline for Tasting and Sensory Evaluation of Novel Foods was developed by the Abu Dhabi Quality and Conformity Council (ADQCC) with the Abu Dhabi Agriculture and Food Safety Authority (ADAFSA) and the Abu Dhabi Investment Office (ADIO). It was presented at the PALT 2026 conference during Global Food Week UAE.

How the pathway works

The guideline covers cell-cultivated foods, alternative proteins, precision fermentation products and other new food ingredients. Companies can carry out tasting and sensory studies inside a controlled research setting rather than a commercial one, with requirements set for:

• product safety assessment before any human exposure;
• laboratory testing and verification;
• regulatory oversight of each trial; and
• protection of the people taking part.

Roles are split between agencies. ADAFSA reviews trial applications and issues the approvals needed to run them, while ADQCC’s Central Testing Laboratory provides lab verification and technical evaluation. The rules were drafted with input from international novel food companies, academics and regulators through a working group convened by ADIO’s AgriFood Growth and Water Abundance (AGWA) cluster.

Closing the gap between R&D and market entry

Developers of cultivated and fermentation-derived foods usually face a catch-22: they need consumer sensory data to refine products, support investment cases and prepare dossiers, but in many markets they cannot legally serve unapproved products to the public. Some jurisdictions have created limited routes. The Netherlands, for example, agreed a code of practice for controlled cultivated meat tastings in 2023. Abu Dhabi’s version formalises the process at government level and links it directly to the authority that will later rule on market approval.

Officials are also selling the emirate’s demographics as a research asset. With residents from many nationalities and cultural backgrounds, companies can test acceptance across varied taste preferences in one location and generate data relevant to both regional and global launches. ADAFSA acting director-general Dr Tariq Ahmed Al Ameri described the pathway as a responsible route to new foods that keeps consumer safety central.

Part of a wider alternative protein strategy

The tasting guideline follows work started about a year ago by the same three agencies on a framework for approving the sale of alternative proteins, which aims to shorten approval timelines by six to nine months. ADIO is also exploring a four-million-litre precision fermentation facility with Vivici and The EVERY Company. The AGWA cluster, launched in 2024, targets AED 90 billion ($24.5 billion) in additional GDP and 60,000 jobs by 2045, backed by expected investment of AED 128 billion.

Authorities expect the framework to drive research partnerships and demand for specialist food testing services, and to attract foodtech companies setting up R&D operations in the emirate.

What it means for novel food developers

For cultivated meat and precision fermentation start-ups, which face high costs and slow approvals in the EU and US, Abu Dhabi now offers a sequence that runs from regulated tastings to an accelerated approval track and potential local manufacturing capacity. The real test will be practical: how quickly ADAFSA processes trial applications, what data packages it requires, and whether tasting results feed smoothly into full approvals. Companies already working with Singapore’s and the UK’s regulators will likely treat Abu Dhabi as an additional Gulf hub rather than a replacement, but the guideline strengthens the emirate’s case as a launch market for next-generation proteins.